A blood-based liquid biopsy test detects early-onset colorectal cancer with strong diagnostic performance and high ...

BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the selection of ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...

VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces results from a clinical study demonstrating the high accuracy of its Nu.Q® Vet Feline assay in ...

Paves the Way for World's First Feline Liquid Biopsy Test for Cancer Detection HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ...

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...

Following the 2024 FDA approval of a new self-collection test to detect HPV, the U.S. Preventive Services Task Force ...

The multi-national epigenetics company reported that its Nu.Q® Vet Feline assay demonstrated remarkable accuracy in detecting lymphoma in cats, the most common cancer affecting the species. At 100% ...

Pancreatitis is excruciatingly painful, especially after eating. The pancreas is behind the lower part of the stomach, ...

Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

The technique referred to is non-invasive preimplantation genetic testing (niPGT), also called non-invasive chromosomal ...

A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...